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Characterization of Monoclonal Antibodies to Avian Escherichia coli Iss
Abstract
Colibacillosis accounts for annual multimillion dollar losses in the poultry industry, and control of this disease
is hampered by limited understanding of the virulence mechanisms used by avian pathogenic Escherichia coli
(APEC). Previous work in our laboratory has found that the presence of the increased serum survival gene
(iss) is strongly associated with APEC but not commensal E. coli, making iss and the protein it encodes (Iss)
candidate targets of colibacillosis-control procedures. Previously, we produced monoclonal antibodies
(MAbs) against Iss to be used as a reagent in studies of APEC virulence and colibacillosis pathogenesis.
Unfortunately, the utility of these MAbs was limited because these MAbs exhibited nonspecific binding. It
was thought that the lack of specificity might be related to the fact that these MAbs were of the
immunoglobulin M (IgM) isotype. In the present study, new MAbs were produced using a different
immunization strategy in an effort to generate MAbs of a different isotype. Also, because Iss bears strong
similarity to Bor, a lambda-derived protein that occurs commonly among E. coli, MAbs were assessed for their
ability to distinguish Iss and Bor. For these studies, the bor gene from an APEC isolate was cloned into an
expression vector. The fusion protein expressed from this construct was used to assess the potential of the
anti-Iss MAbs produced in the past and present studies to distinguish Bor and Iss. The MAbs produced in this
study were of the IgG1 isotype, which appeared to bind more specifically to Iss than previously generated
antibodies in certain immunologic procedures. These results suggested that the MAbs generated in this study
might prove superior to the previous MAbs as a reagent for study of APEC. However, both MAbs recognized
recombinant Iss and Bor, suggesting that any results obtained using anti-Iss MAbs would need to be
interpreted with this cross-reactivity in mind.
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SUMMARY. Colibacillosis accounts for annual multimillion dollar losses in the poultry industry, and control of this disease is
hampered by limited understanding of the virulence mechanisms used by avian pathogenic Escherichia coli (APEC). Previous work in
our laboratory has found that the presence of the increased serum survival gene (iss) is strongly associated with APEC but not
commensal E. coli, making iss and the protein it encodes (Iss) candidate targets of colibacillosis-control procedures. Previously, we
produced monoclonal antibodies (MAbs) against Iss to be used as a reagent in studies of APEC virulence and colibacillosis
pathogenesis. Unfortunately, the utility of these MAbs was limited because these MAbs exhibited nonspecific binding. It was thought
that the lack of specificity might be related to the fact that these MAbs were of the immunoglobulin M (IgM) isotype. In the present
study, new MAbs were produced using a different immunization strategy in an effort to generate MAbs of a different isotype. Also,
because Iss bears strong similarity to Bor, a lambda-derived protein that occurs commonly among E. coli, MAbs were assessed for their
ability to distinguish Iss and Bor. For these studies, the bor gene from an APEC isolate was cloned into an expression vector. The fusion
protein expressed from this construct was used to assess the potential of the anti-Iss MAbs produced in the past and present studies to
distinguish Bor and Iss. The MAbs produced in this study were of the IgG1 isotype, which appeared to bind more specifically to Iss
than previously generated antibodies in certain immunologic procedures. These results suggested that the MAbs generated in this
study might prove superior to the previous MAbs as a reagent for study of APEC. However, both MAbs recognized recombinant Iss
and Bor, suggesting that any results obtained using anti-Iss MAbs would need to be interpreted with this cross-reactivity in mind.
RESUMEN. Nota de Investigacio´n—Caracterizacio´n de anticuerpos monoclonales contra la proteı´na Iss de Escherichia coli aviar.
La colibacilosis es responsable anualmente por pe´rdidas multimillonarias en la industria avı´cola y el control de esta enfermedad
esta´ restringido por el limitado conocimiento de los mecanismos de virulencia utilizados por las cepas pato´genas aviares de
Escherichia coli. Trabajos previos en nuestro laboratorio han encontrado que la presencia del gen de supervivencia incrementada en
suero (iss por sus siglas en Ingle´s) esta´ fuertemente asociada con las cepas pato´genas aviares de E. coli, pero no con las cepas normales
o no pato´genas de E. coli, lo que hace del gen de supervivencia incrementada en suero y la proteı´na para la cual codifica (por sus
siglas en ingle´s Iss) el blanco de los procedimientos de control para colibacilosis. Con anterioridad, produjimos anticuerpos
monoclonales contra la proteı´na Iss para ser utilizados en los estudios de virulencia de las cepas pato´genas aviares de E.coli y la
patoge´nesis de la colibacilosis. Desafortunadamente, la utilidad de estos anticuerpos monoclonales fue limitada debido a que los
anticuerpos mostraron uniones inespecı´ficas. Se penso´ que la falta de especificidad podrı´a estar relacionada con el hecho de que estos
anticuerpos monoclonales eran del isotipo IgM. En el presente estudio, se produjeron nuevos anticuerpos monoclonales utilizando
una estrategia de inmunizacio´n diferente, tratando de generar anticuerpos monoclonales de un isotipo distinto. Ası´ mismo, debido
a que la proteı´na Iss posee una fuerte similitud con una proteı´na derivada–Lamda (Bor) de ocurrencia comu´n entre las cepas de
E. coli, los anticuerpos monoclonales se evaluaron por su capacidad para distinguir entre Iss y Bor. Para estos estudios el gen Bor de
un aislamiento de E. coli pato´gena aviar se clono´ en un vector de expresio´n. La proteı´na de fusio´n expresada de este ensamble se
utilizo´ para evaluar el potencial de los anticuerpos monoclonales anti- Iss producidos en los estudios anteriores y en los presentes de
distinguir entre Iss y Bor. Los anticuerpos monoclonales producidos en este estudio fueron del isotipo IgG1 los cuales en ciertos
procedimientos inmunolo´gicos se unieron ma´s especı´ficamente a la proteı´na Iss que los anticuerpos generados con anterioridad.
Estos resultados sugieren que los anticuerpos monoclonales generados en este estudio pueden ser superiores a los anticuerpos
monoclonales previos, como un reactivo para el estudio de las cepas pato´genas aviares de E. coli. Sin embargo, ambos anticuerpos
monoclonales reconocieron la proteı´nas Iss y Bor recombinantes, lo que sugiere que cualquier resultado obtenido utilizando
anticuerpos monoclonales Iss tendrı´a que ser interpretado teniendo en cuenta esta reactividad cruzada.
Key words: APEC, avian colibacillosis, Bor, Iss, monoclonal antibody
Abbreviations: APEC ¼ avian pathogenic Escherichia coli; Bor ¼ blue open-reading frame protein; DMEM ¼ Dulbecco’s
modified Eagle medium; ELISA¼ enzyme-linked immunosorbent assay; GST¼ glutathione-S-transferase; Ig¼ immunoglobulin;
Iss ¼ increased serum-survival protein; IPTG ¼ isopropyl-b-D-thiogalactopyranoside; LB ¼ Luria–Bertani; MAbs ¼ monoclonal
antibodies; PCR ¼ polymerase chain reaction; PEG ¼ polyethylene glycol; PVDF ¼ polyvinylidine difluoride; SDS-PAGE ¼
sodium dodecyl sulfate–polyacrylamide gel electrophoresis; Tm ¼melting temperature
Colibacillosis, caused by avian pathogenic Escherichia coli
(APEC), is a major problem for the poultry industry in the United
States, resulting in annual multimillion-dollar losses (1). One of the
problems encountered in colibacillosis control is that no single
bacterial trait has been identified that can be used as an identifier
of APEC strains (1). Previous work has shown that complement
resistance may play an important role in APEC virulence
(11,13,15,22), suggesting that traits contributing to complement
resistance might have value as identifiers of APEC strains. Previously,
it was shown that the increased serum survival (iss) gene (4), which
is associated with E. coli complement resistance (4,5,6), was found
significantly more often in APEC than it was in commensal E. coliCCorresponding author.
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isolates of apparently healthy birds (16,18). This strong association
between iss and disease-causing E. coli of birds suggested to us that
iss-centric strategies might be useful in controlling colibacillosis and
in studying the pathogenesis of avian colibacillosis.
The iss gene was first described by Binns et al. (4) for its role in
complement resistance associated with a ColV plasmid of a human
E. coli isolate. Iss, the protein product of iss, is thought to occur as
a 10–11-kDa lipoprotein in the bacterial outer membrane (3,10). iss
may be a derivative of bor, a gene of bacteriophage k (2,3,5,10). The
blue open-reading (Bor) frame protein, a lipoprotein of the cell
envelope of E. coli k lysogens, appears to confer complement
resistance on these lysogens (2). Amino acid sequences of Iss and
Bor are about 90% identical (10).
Previously, we produced monoclonal antibodies (MAbs) against
recombinant Iss to be used as a reagent in the study of APEC virulence
and control (7). Using a ‘‘two fusion protein approach,’’ where two
different Iss fusion proteins were used to immunize mice, MAbs were
generated that recognized recombinant Iss. Isotyping of these MAbs
revealed that they were of the immunoglobulin (Ig) M isotype. It was
felt that IgM MAbs might be less desirable for diagnostic purposes
than those of the IgG type because IgM antibodies are larger and bind
less specifically than IgG antibodies (19).
Further, IgG antibodies may be preferred for number of reasons.
First, they are easier to purify from tissue-culture supernatants,
allowing for more concentrated antibody preparations for antibody-
testing regimes (9). Second, IgG antibodies have a longer half-life
than IgM, which may be important for maintaining the stability
and affinity of antibodies for use in diagnostics (19). Finally, IgG
molecules have more flexibility, allowing them to better align with
the antigenic portion of a molecule, providing a higher affinity to
antigens than IgM (9). This trait is important in increasing the
specificity of diagnostic methods. Additionally, a factor determining
the utility of anti-Iss MAbs could lie in their ability to discriminate
between Iss and Bor because Bor is quite similar in structure to Iss
and is widespread among E. coli (10).
Therefore, a MAb of the IgG isotype, able to discriminate
between Iss and Bor proteins, was sought in this study. It is thought
that such a MAb could prove useful as a reagent for the study of
avian E. coli and avian colibacillosis.
MATERIALS AND METHODS
Bacterial strains and plasmids. Strains used were E. coli BL21
(DE3) (Stratagene, La Jolla, CA) and E. coli JM109 (Promega, Madison,
WI). E. coli BL21 was used for expression of GST–Iss and GST–Bor and
E. coli JM109 was used in the creation of the pALbor construct. All
strains were maintained on Luria-Bertani (LB) agar (Difco, Detroit, MI)
with ampicillin (100 lg/ml; Amresco, Solon, OH) where appropriate.
The plasmids used in this study were pGEM-T Easy (Promega), pGEX-
6P-3 (Pharmacia Biotech, Piscataway, NJ), pLN320, pLN330, and
pALbor. pGEM-T Easy is a TA cloning vector designed for easy cloning
of polymerase chain reaction (PCR) products. pGEX-6p-3 is a plasmid-
expression vector designed for production of proteins fused to
glutathione-S-transferase (GST). pLN330 is composed of pGEX-6P-3
with the iss gene sequence (GenBank accession AF0422279) without the
coding region for the signal sequence (the first 72 nucleotides of iss) (8).
pLN320 is composed of pGEX-6P-3 with the iss gene sequence with
the coding region for the signal sequence (8). pALbor is composed of
pGEX-6P-3 with the bor gene sequence (GenBank accession X55792).
Molecular cloning. To amplify the bor gene for creation of
pALbor, the upper primer was 59 TTTTCTACACATACGATTCT-
GCGAACT 39, melting temperature (Tm): 56.5 C, and lower primer
59 CTCGATGCAAAATACACGAAGGAGTTAGCT 39, Tm: 60.1 C.
The amplification program used was 94 C for 5 min; 30 cycles of 94 C
for 30 sec, 55 C for 30 sec, 72 C for 30 sec; then 72 C for 7 min, and
hold at 4 C. The amplified bor gene was prepared for ligation using
the Wizard PCR preps DNA purification system (Promega). The bor
amplicon was ligated into pGEM-T Easy, and the recombinant plasmid
DNA was used to transform E. coli JM109 competent cells according
to manufacturer’s protocol (Promega). Plasmid DNA was purified from
these transformants using Wizard Plus Minipreps DNA Purification
System (Promega) and digested with EcoRI for 2 hr at 37 C. Digests
were run on 1% low-melt agarose gel, stained with ethidium bromide,
and viewed under ultraviolet light. A 648-base-pair band, correspond-
ing in size to the predicted bor amplicon, was excised from the gel
and purified from the agarose using MinElute Gel Extraction Kit
(Qiagen, Valencia, CA ). EcoRI-digested bor was ligated into pGEX-6P-
3 according to manufacturer’s protocol (Pharmacia) to form pALbor.
Ligations were transformed in BL21 (DE3) using the calcium chloride
method (20).
DNA sequencing. Clones were sequenced to confirm inserts were
in the correct orientation and were ‘‘in frame’’ for protein expression.
Double-stranded plasmid clones were sequenced at the Iowa State
University DNA Sequencing and Synthesis Facility (Ames, IA) with
the BigDye Terminator Cycle Sequencing Ready Reaction Kit (PE
Biosystems, Foster City, CA).
Protein expression. The GST–Iss and GST–Bor fusion proteins
were generated as described below. Briefly, E. coli BL21 (DE3)
containing either pLN330 or pALbor were grown overnight on LB
plates supplemented with ampicillin (50 lg/ml). Individual colonies
were transferred to LB broth containing ampicillin (50 lg/ml), and the
cultures were grown at 37 C with shaking to an optical density600 of
0.5. Isopropyl-b-D-thiogalactopyranoside (IPTG) was added to the final
concentration of 0.1 mM, and the cultures were incubated for an
additional 4 hr. Protein expression was confirmed by sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS-PAGE). Samples were
loaded into wells of 15% Criterion gels (Bio-Rad) for separation in the
Criterion System (Bio-Rad). Samples were electrophoresed at 200 V for
70 min. The gels were stained using SafetyBlue SafeStain (Invitrogen).
Gels not stained were transferred to polyvinylidine difluoride (PVDF)
membrane and probed with the anti-GST primary antibody and alkaline
phosphatase–conjugated goat anti-mouse IgG secondary antibody. The
membrane was developed using Bio-Rad immuno-blot color de-
velopment reagent (5-bromo-4-chloro-3-indoyl phosphate and nitroblue
tetrazolamine in dimethylformamide).
Protein purification. Lysis and solubilization of the GST–Iss
fusion protein was accomplished following expression of pLN330.
Induced cells were lysed with Bacterial-Protein Extraction Reagent
(Pierce, Rockford, IL), and the inclusion body was solubilized with
Inclusion Body Solubilization Reagent (Pierce) following manufacturer’s
protocol. GST–Iss was purified using an Immobilized Glutathione
column (Pierce). For Iss purification, GST–Iss was cleaved using
PreScission protease (Pharmacia), and cleaved GST was removed by
passage through the Immobilized Glutathione column.
Hybridoma generation. Hybridoma generation was done in
conjunction with Iowa State University’s Hybridoma Facility (Ames, IA)
following an approved Institutional Animal Care and Use Committee
protocol. Briefly, three BALB/c mice were injected with 25 lg of GST–
Iss in Freund’s Complete Adjuvant subcutaneously. The mice were given
two booster injections 2 wk apart with 25 lg of GST–Iss in Incomplete
Freund’s Adjuvant given intraperitoneally. Two weeks after the last
boost, mice were bled, and the sera were tested to determine antibody
titer using enzyme-linked immunosorbent assay (ELISA). Hybridomas
were produced by the fusion of splenocytes from hyperimmune BALB/c
mice and SP2/O mouse myeloma cells with the use of polyethylene
glycol (PEG). The BALB/c mouse with the highest titer was
euthanatized by carbon dioxide asphyxiation, its spleen was aseptically
harvested, and its splenocytes were collected by syringe perfusion with
sterile Dulbecco’s modified Eagle medium (DMEM) (13). Splenocytes
and SP2/O cells were combined at a 1:1 ratio and centrifuged at 2003 g
for 8 min. One milliliter of PEG was slowly added to the pellet,
followed by the gradual addition of 10 ml of DMEM and incubation for
5 min at 37 C. The mixture was centrifuged at 2003 g for 8 min and
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resuspended in a volume of media containing DMEM, 10% horse
serum, 0.1 mM hypoxanthine, 0.004 mM aminopterin, 0.016 mM
thymidine, penicillin [63 lg/ml], streptomycin [0.1 mg/ml], fungizone
[0.25 lg/ml], 2 mM L-glutamine, and 50% myeloma-conditioned
media, such that the concentration was 23 106 cells/ml, and 0.2 ml of
the hybridoma mixture was dispensed into a 96-well tray and incubated
at 37 C. After 5 days, cells were fed with a mixture containing DMEM,
10% horse serum, 50% conditioned media, hypoxanthine and
thymidine (without aminopterin) to select for hybridomas.
Hybridoma screening for anti-Iss antibody production.
As soon as hybridoma growth was observed, cell-free supernatant fluid
was screened for the presence of antibodies against Iss. Screening was
done, as previously described (17) by ELISA, using cleaved Iss as the
coating antigen.
Dilution cloning and expansion. Hybridomas that screened
positive against Iss by ELISA were serially diluted in 96-well trays to
isolate single clones (13). Wells with growth of a single colony were
screened for Iss recognition by ELISA. Wells with MAbs that recognized
Iss were sequentially expanded into flasks. During expansion, the
amount of horse serum was reduced to 2%. Cell-free supernatant was
collected for MAb purification (9,13).
Isotyping. After expansion, MAbs were characterized with Mouse
Typer Sub-isotyping Kit (Bio-Rad) according to the manufacturer’s
protocol. Cleaved Iss was used as the coating antigen for the isotyping
ELISA.
MAb purification. MAbs were purified using MAbTrap Kit
(Amersham Biosciences) according to manufacturer’s instructions.
Specificity of MAbs. To test the specificity of anti-Iss
MAbs, lysates of E. coli BL21 (DE3), BL21 (DE3) containing pGEX-
6P-3, BL21 (DE3) containing pLN320, BL21 (DE3) containing
pLN330, and BL21 (DE3) containing pALbor were subjected to
SDS-PAGE, blotted onto PVDF membranes and probed with anti-Iss
MAbs (diluted 1:1000 in phosphate-buffered saline) as previously
described (14).
RESULTS
To generate MAbs specific for Iss, a GST–Iss fusion protein was
produced. Expression of GST–Iss from BL21 (DE3) containing
pLN330 (pGEX-6P-3 containing iss without the signal sequence)
was induced with IPTG. Cells were then harvested and lysed.
Inclusion bodies were solubilized, and the fusion protein was
purified by affinity chromatography (Fig. 1) and used for im-
munization. Recombinant Iss was produced for use in screening of
MAbs (12). Iss was cleaved from its fusion partner with PreScission
Protease, and its fusion partner was removed (12).
In an effort to help characterize anti-Iss MAbs, a recombinant Bor
fusion protein was produced. To produce GST–Bor, bor was cloned
into pGEX-6P-3. The resulting construct was termed pALbor. DNA
sequencing of the construct confirmed that bor was ligated in the
correct reading frame for proper expression. Cell lysates of induced
BL21-(DE3) pALbor contained a 37-kD protein corresponding to
the GST–Bor protein product (Fig. 2).
Mice immunized with GST–Iss were able to generate an immune
response against Iss, as shown by ELISA, with sera from three
immunized mice after their second boost of GST–Iss. Sera from
immunized mice reacted with purified Iss protein at a dilution of
1:1000. Sera from unimmunized mice did not react with Iss. The
mouse with the greatest antibody response to Iss was used to gen-
erate MAbs.
Two weeks after the fusion, hybridomas were screened for anti-Iss
MAb production by ELISA. Ten wells gave a positive response and
were subsequently subcloned. When growth was observed in the
Fig. 1. SDS-PAGE of purified protein (GST–Iss) obtained after
expression of pLN330 in BL21, lysis with Bacterial Protein Extrac-
tion Reagent, solubilization with Inclusion Body Solubilization
Reagent, and purification with glutathione sepharose 4B. Lane S ¼ the
molecular weight standard (Bio-Rad prestained molecular weight
standard) with sizes given in kilodaltons (kDs); lane 1 ¼ BL21 cell
lysate; lane 2¼ cell lysate of pLN330 in BL21 induced with IPTG; lane
3 ¼ column flow-through of BL21 pLN330 cell lysate; and lane
4 purified GST–Iss.
Fig. 2. SDS-PAGE to detect the presence of expressed recombinant
proteins in BL21. Lane S ¼ the molecular weight standard (Bio-Rad
prestained molecular weight standard); lane 1 ¼ BL21 cell lysate; lane
2 ¼ BL21 with pGEX-6P-3 following induction with IPTG; lane 3 ¼
BL21 with pLN330 following induction with IPTG; lane 4 ¼ BL21
with pLN320 following induction with IPTG; and BL21 with pALbor
following induction with IPTG. Recombinant proteins GST, GST–Iss
without signal sequence, GST–Iss with signal sequence, and GST–Bor
were expressed as shown in lanes 2–5, respectively.
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cloning plates, 40 subclones were rescreened by ELISA. Of the
40 subclones, the five that gave the strongest response were expanded
and isotyped. Each subclone produced antibodies of the IgG1
subclass with j-light chains.
MAbs were evaluated for their specificity to Iss by western
blotting. Of the five MAbs produced, MAb 8B10-5B7 showed the
greatest affinity for Iss and was used for the remainder of the study.
MAb 8B10-5B7 recognized bands corresponding in size to GST–Iss
with and without the signal sequence. The antibody did not
recognize any proteins from BL21 (DE3) alone or BL21 (DE3) with
p-GEX-6P-3 (expresses GST only). MAb 8B10-5B7 also recognized
a band corresponding to GST–Bor (Figs. 2, 3).
DISCUSSION
Avian colibacillosis is a costly disease to the poultry industry,
accounting for multimillion-dollar losses annually (1). Previous
work in our lab has shown that iss is strongly associated with APEC
but not with fecal isolates from apparently healthy birds (16,18),
making iss and the protein it encodes, Iss, potential identifiers of
virulent isolates. To generate MAbs for use as reagents in the study
of APEC and colibacillosis, iss was previously cloned into two
different expression vectors to express two fusion proteins, GST–Iss
and calmodulin-binding protein (CBP)–Iss (7). These proteins were
used in a ‘‘two-fusion protein immunization strategy’’ to produce
MAbs against Iss. The reasoning behind this approach was to select
plasma cells producing antibodies specific for Iss by immunizing
mice with GST–Iss for the first few immunizations, then switching
to CBP–Iss for the last booster. Results of this strategy yielded MAbs
of the IgM class. During subsequent characterization of these MAbs,
it was found that they may bind nonspecifically to the surface of iss-
negative controls, making use of these MAbs for diagnostic purposes
problematic. It was thought that the lack of specificity of these MAbs
might be due to their being of the IgM class and that the ‘‘two-
immunogen’’ approach used in MAb generation may have skewed
the immune response towards IgM production.
Consequently, in the present study, a single fusion protein
immunization strategy, where mice were immunized with GST–Iss
only, was used in antibody generation in an effort to generate MAbs
of a non-IgM type. Using this approach, MAbs of the IgG type were
successfully produced. However, production of anti-Iss MAbs using
only GST–Iss presents other problems. For instance, GST is ap-
proximately three times larger than Iss, presenting the possibility that
the majority of antibodies produced will be directed against GST not
Iss. To detect hybridomas producing antibodies against Iss only,
ELISA was performed with purified Iss cleaved from GST–Iss.
During characterization of MAb 8B10-5B7, western blots were
performed to see whether 8B10-5B7 would bind to GST without
Iss. Results showed that MAb 8B10-5B7 would bind to GST–Iss
with and without the signal sequence but not to GST alone,
suggesting that the MAbs were directed against Iss alone.
Also of concern was the potential that these anti-Iss MAbs might
cross-react with Bor, a protein showing strong homology to Iss (10).
For these studies, a second fusion protein, GST–Bor was produced.
MAbs were screened by western blot for their specificity to the Bor
fusion protein. Results showed that MAb 8B10-5B7 did bind to
recombinant Bor. Although these results are undesirable, they are
not surprising given that Bor and Iss share about 90% homology
(10). Further characterization will be necessary to determine whether
such cross-reacting MAbs will be useful as reagents in the study to
colibacillosis.
MAbs directed against outer-membrane proteins have been useful
in the study and diagnosis of other organisms. For example, MAbs
directed against outer-membrane proteins have been used in
a surface-adhesion immunofluorescent technique for rapid detection
of Yersinia enterocolitica in meat (21). MAbs could also be used to
confirm the presence of Iss on the outer membrane and determine
the level of Iss expression between virulent and avirulent isolates.
In spite of colibacillosis’ devastating effects on the poultry
industry, understanding of the virulence mechanisms of APEC have
been hampered by the lack of a distinguishing characteristic of
virulent isolates. From the results of Pfaff-McDonough et al. (16), iss
appears to be a characteristic that can distinguish virulent from
avirulent APEC isolates. In the present study, IgG MAbs were
generated that may be a useful tool to confirm Iss’s location on the
bacterium, to study the interaction of Iss and its complement, and to
detect virulent strains in the environment.
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